Schedule 13G ownership disclosure

RAPT THERAPEUTICS INC

Common Stock · CUSIP: 75382E109

Event date: 2024-12-23

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Foresite Capital Fund VI, L.P.

    Shares: 12,500,000.00 · Class: 9.3%

  • Foresite Capital Management VI, LLC

    Shares: 12,500,000.00 · Class: 9.3%

  • James Tananbaum

    Shares: 12,500,000.00 · Class: 9.3%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-132464
Form type
SCHEDULE 13G
Filer
Foresite Capital Fund VI LP
CIK
CIK 1932516
Filed
Dec 30, 2024
Reporting period
Dec 23, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub